Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models

European Journal of Neuroscience

Volumn 17, Issue 12, 2003, Pages 2750-2754

  Zhang, Ji ^a   Hoffert, Cyrla ^a   Vu, Huy Khang ^a   Groblewski, Thierry ^a   Ahmad, Sultan ^a   O'Donnell, Dajan ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

Cannabinoids; Inflammation; Nerve injury

Indexed keywords

CANNABINOID; CANNABINOID 2 RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC PAIN; CONTROLLED STUDY; HYPERALGESIA; IMMUNOCOMPETENT CELL; INFLAMMATION; LUMBAR SPINAL CORD; MALE; MICROGLIA; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD11; ANTIGENS, CD147; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; AVIAN PROTEINS; BLOOD PROTEINS; DISEASE MODELS, ANIMAL; ECTODYSPLASINS; FREUND'S ADJUVANT; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICROGLIA; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB2; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; RNA, MESSENGER; SCIATIC NEUROPATHY; SPINAL CORD INJURIES; TIME FACTORS;

EID: 0038684167     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02704.x     Document Type: Article

References (28)

1. Altman, J. (1994) Microglia emerge from the fog. Trends Neurosci., 17, 47-49.
2. Bennett, G.J. & Xie, Y.K. (1988) A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain, 33, 87-107.
3. Berdyshev, E.V. (2000) Cannabinoid receptors and the regulation of immune response. Chem. Phys. Lipids, 108, 169-190.
4. Buckley, N.E., McCoy, K.L., Mezey, E., Bonner, T., Zimmer, A., Felder, C.C., Glass, M. & Zimmer, A. (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur. J. Pharmacol., 396, 141-149.
5. Calignano, A., La Rana, G., Giuffrida, A. & Piomelli, D. (1998) Control of pain initiation by endogenous cannabinoids. Nature, 394, 277-281.
6. Cao, J., O'Donnell, D., Vu, H., Payza, K., Pou, C., Godbout, C., Jakob, A., Pelletier, M., Lembo, P., Ahmad, S. & Walker, P. (1998) Cloning and characterization of a cDNA encoding a novel subtype of rat thyrotropin-releasing hormone receptor. J. Biol. Chem., 273, 32,281-32,287.
7. Clayton, N., Marshall, F.H., Bountra, C. & O'Shaughnessy, C.T. (2002) CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain, 96, 253-260.
8. Derocq, J.M., Jbilo, O., Bouaboula, M., Segui, M., Clere, C. & Casellas, P. (2000) Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J. Biol. Chem., 275, 15,621-15,628.
9. Farquhar-Smith, W.P., Egertova, M., Bradbury, E.J., McMahon, S.B., Rice, A.S. & Elphick, M.R. (2000) Cannabinoid CB(1) receptor expression in rat spinal cord. Mol. Cell Neurosci., 15, 510-521.
10. Fox, A., Kesingland, A., Gentry, C., McNair, K., Patel, S., Urban, L. & James, I. (2001) The role of central and peripheral Cannabinoidl receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain, 92, 91-100.
11. Galiegue, S., Mary, S., Marchand, J., Dussossoy, D., Carriere, D., Carayon, P., Bouaboula, M., Shire, D., Le Fur, G. & Casellas, P. (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem., 232, 54-61.
12. Hanus, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R.G., Ross, R.A., Mechoulam, R. & Fride, E. (1999) HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proc. Natl. Acad. Sci. USA, 96, 14,228-14,233.
13. Hohmann, A.G. & Herkenham, M. (1999) Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience, 92, 1171-1175.
14. Jaggar, S.I., Hasnie, F.S., Sellaturay, S. & Rice, A.S. (1998) The anti-hyperalgesic actions of the cannabinoid anandamide and the putative CB2 receptor agonist palmitoylethanolamide in visceral and somatic inflammatory pain. Pain, 76, 189-199.
15. Kim, S.H. & Chung, J.M. (1992) An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain, 50, 355-363.
16. Matsuda, L.A., Lolait, S.J., Brownstein, M.J., Young, A.C. & Bonner, T.I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346, 561-564.
17. Meng, I.D., Manning, B.H., Martin, W.J. & Fields, H.L. (1998) An analgesia circuit activated by cannabinoids. Nature, 395, 381-383.
18. Milligan, E.D., O'Connor, K.A., Nguyen, K.T., Armstrong, C.B., Twining, C., Gaykema, R.P., Holguin, A., Martin, D., Maier, S.F. & Watkins, L.R. (2001) Intrathecal HIV-1 envelope glycoprotein gp120 induces enhanced pain states mediated by spinal cord proinflammatory cytokines. J. Neurosci., 21, 2808-2819.
19. Munro, S., Thomas, K.L. & Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365, 61-65.
20. Panikashvili, D., Simeonidou, C., Ben Shabat, S., Hanus, L., Breuer, A., Mechoulam, R. & Shohami, E. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature, 413, 527-531.
21. Puffenbarger, R.A., Boothe, A.C. & Cabral, G.A. (2000) Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia, 29, 58-69.
22. Richardson, J.D., Aanonsen, L. & Hargreaves, K.M. (1998) Antihyperalgesic effects of spinal cannabinoids. Eur. J. Pharmacol., 345, 145-153.
23. Sacerdote, P., Massi, P., Panerai, A.E. & Parolaro, D. (2000) In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors. J. Neuroimmunol., 109, 155-163.
24. Sweitzer, S., Martin, D. & DeLeo, J.A. (2001a) Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience, 103, 529-539.
25. Sweitzer, S.M., Schubert, P. & DeLeo, J.A. (2001b) Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J. Pharmacol. Exp. Ther., 297, 1210-1217.
26. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K. & Walker, J.M. (1998) Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 83, 393-411.
27. Watkins, L.R., Milligan, E.D. & Maier, S.F. (2001) Glial activation: a driving force for pathological pain. Trends Neurosci., 24, 450-455.
28. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA, 96, 5780-5785.